Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Scientific Reports|February 18, 2021
Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairmentYuek Ling Chai, Joyce R Chong, Ainiah R Raquib, et al.Apoptosis : an International Journal on Programmed Cell Death|May 24, 2013
An anthraquinone derivative, emodin sensitizes hepatocellular carcinoma cells to TRAIL induced apoptosis through the induction of death receptors and downregulation of cell survival proteinsAruljothi Subramaniam, Ser Yue Loo, Peramaiyan Rajendran, et al.Cancer Treatment Reviews|November 21, 2017
Triple negative breast cancer in Asia: An insider's viewChao Wang, Shreya Kar, Xianning Lai, et al.Oncogenesis|November 6, 2019
A novel small-molecule inhibitor of trefoil factor 3 (TFF3) potentiates MEK1/2 inhibition in lung adenocarcinomaMengyi Zhang, Baocheng Wang, Qing-Yun Chong, et al.Journal of Cellular Physiology|April 19, 2022
Noncoding RNAs and their therapeutics in paclitaxel chemotherapy: Mechanisms of initiation, progression, and drug sensitivityMahmood K Mahabady, Sepideh Mirzaei, Hamidreza Saebfar, et al.Biological Reviews of the Cambridge Philosophical Society|January 30, 2015
microRNAs in breast cancer: regulatory roles governing the hallmarks of cancerJen N Goh, Ser Y Loo, Arpita Datta, et al.British Journal of Pharmacology|July 25, 2017
'Lnc'-ing Wnt in female reproductive cancers: therapeutic potential of long non-coding RNAs in Wnt signallingMei S Ong, Wanpei Cai, Yi Yuan, et al.Nature Reviews. Clinical Oncology|September 1, 2025
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemiaAntonino Glaviano, Ellen Weisberg, Hiu Y Lam, et al.Molecular Cancer Therapeutics|October 13, 2017
PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast CancersLuxi Chen, Yi Yuan, Shreya Kar, et al.Molecular Cancer|August 18, 2023
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancerAntonino Glaviano, Aaron S C Foo, Hiu Y Lam, et al.Pageof 3